SEB Asset Management’s Medline MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.49M Sell
100,643
-61,790
-38% -$2.26M 0.01% 505
2026
Q2
$6.41M Buy
+162,433
New +$6.55M 0.02% 414

Other funds holding MDLN

SEB Asset Management's MDLN Position: Q3 2026 in Review

SEB Asset Management reduced its Medline (MDLN) stake by 38% in Q3 2026, selling an estimated $2.26M and leaving 100,643 shares worth $3.49M. The position accounts for 0.01% of the portfolio, ranked #505.

SEB Asset Management first reported a position in MDLN in Q2 2026 and has held it in 2 quarters since. The position peaked at $6.41M in Q2 2026. 415 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • SEB Asset Management held 100,643 shares of Medline worth $3.49M as of Q3 2026.
  • SEB Asset Management sold 61,790 Medline shares in Q3 2026, an estimated $2.26M.
  • Medline made up 0.01% of SEB Asset Management's portfolio in Q3 2026, its #505 holding.
  • SEB Asset Management first reported a position in Medline in Q2 2026 and has held it in 2 quarters since.
  • SEB Asset Management's Medline position peaked at $6.41M in Q2 2026.
  • 415 funds tracked by Wall St. Rank held Medline as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.